Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis

Fig. 2

Cumulative incidence plot of exacerbations requiring hospitalization and all-cause mortality in propensity score matched patient groups treated with ICS delivered by low and high climate impact inhalers. Patients were propensity score matched 1:1 by age, gender, tobacco exposure, exacerbations requiring hospitalization, MRC, BMI, FEV1% and daily dosage of inhaled corticosteroids in the year before entry date as well as entry year. The primary outcome is a composite outcome of exacerbations requiring hospitalization (admissions diagnosed as DJ44 Chronic obstructive pulmonary disease and all belonging subcodes) and all-cause mortality

Back to article page